Women and men are equally disabled by Charcot-Marie-Tooth disease type 1A

被引:8
作者
Swan, Emily R.
Fuerst, Darren R.
Shy, Michael E.
机构
[1] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA
[2] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA
关键词
D O I
10.1212/01.wnl.0000256818.43819.da
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:873 / 873
页数:1
相关论文
共 5 条
[1]   VARIABLES INFLUENCING NEUROPATHIC END-POINTS - THE ROCHESTER DIABETIC NEUROPATHY STUDY OF HEALTHY-SUBJECTS [J].
DYCK, PJ ;
LITCHY, WJ ;
LEHMAN, KA ;
HOKANSON, JL ;
LOW, PA ;
OBRIEN, PC .
NEUROLOGY, 1995, 45 (06) :1115-1121
[2]   Diverse modes of action of progesterone and its metabolites [J].
Mahesh, VB ;
Brann, DW ;
Hendry, LB .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 56 (1-6) :209-219
[3]   Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) [J].
Sereda, MW ;
Hörste, GMZ ;
Suter, U ;
Uzma, N ;
Nave, KA .
NATURE MEDICINE, 2003, 9 (12) :1533-1537
[4]   CMT1X phenotypes represent loss of GJB1 gene function [J].
Shy, M. E. ;
Siskind, C. ;
Swan, E. R. ;
Krajewski, K. M. ;
Doherty, T. ;
Fuerst, D. R. ;
Ainsworth, P. J. ;
Lewis, R. A. ;
Scherer, S. S. ;
Hahn, A. F. .
NEUROLOGY, 2007, 68 (11) :849-855
[5]   Reliability and validity of the CMT neuropathy score as a measure of disability [J].
Shy, ME ;
Blake, J ;
Krajewski, K ;
Fuerst, DR ;
Laura, M ;
Hahn, AF ;
Li, J ;
Lewis, RA ;
Reilly, M .
NEUROLOGY, 2005, 64 (07) :1209-1214